ストックスクリーナーアプリを入手
5.60
0.18%
-0.01
プレマーケット:
5.50
-0.10
-1.79%
Rxsight Inc (RXST) 最新ニュース
Bronstein, Gewirtz & Grossman, LLC Encourages RxSight, Inc. (RXST - The National Law Review
RxSight, Inc.(NasdaqGM: RXST) dropped from Russell 2500 Growth Benchmark - marketscreener.com
RxSight, Inc.(NasdaqGM: RXST) added to Russell Microcap Value Benchmark Index - marketscreener.com
RxSight, Inc.(NasdaqGM: RXST) added to Russell 2000 Value Benchmark - marketscreener.com
RxSight, Inc.(NasdaqGM: RXST) dropped from Russell 2000 Growth Benchmark - marketscreener.com
RxSight, Inc.(NasdaqGM: RXST) dropped from Russell 3000E Growth Benchmark - marketscreener.com
RxSight, Inc.(NasdaqGM: RXST) added to Russell Microcap Index - marketscreener.com
Class Action Alert: Levi & Korsinsky Reminds RxSight, Inc. (RXST) Investors of September 22, 2025 Deadline - The National Law Review
Liquidity Mapping Around (RXST) Price Events - Stock Traders Daily
RXST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
RXST Stockholders Have Opportunity to Lead RxSight, Inc. Class Ac - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Is Investigating RxSight, Inc. (RXST) And Encourages Investors to Connect - The National Law Review
Lost Money on RxSight, Inc. (RXST)? Contact Levi & Korsinsky Before September 22, 2025 to Join Class Action - The National Law Review
RxSight, Inc. (RXST) Investigation: Bronstein, Gewirtz & Grossman - The National Law Review
RXST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
RXST Forecast — Price Target — Prediction for 2027 - TradingView
RxSight, Inc. Actuals & Estimates (NASDAQ:RXST) - TradingView
RxSight, Inc. Actuals & Estimates (BOATS:RXST) - TradingView
Rxsight Inc (RXST) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
RXST SEC FilingsRxsight, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Rxsight Inc (RXST) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
RxSight (RXST) director receives 37,037 restricted stock units in equity grant - Stock Titan
RxSight (RXST) director awarded 37,037 RSUs in equity compensation grant - Stock Titan
RxSight (RXST) director Shweta Maniar receives 37,037 RSU award - Stock Titan
Tamara Fountain at RxSight (RXST) receives 37,037-share RSU award - Stock Titan
RxSight (RXST) director William J. Link granted 37,037-share stock award - Stock Titan
RxSight (RXST) director Corley Jesse Anderson granted 37,037 RSUs - Stock Titan
RxSight (RXST) director granted 30,864 RSUs vesting by next meeting - Stock Titan
RxSight (RXST) director receives 37,037 RSUs vesting by next stockholder meeting - Stock Titan
RxSight (RXST) director receives 37,037 RSUs, now directly holds 85,183 shares - Stock Titan
Rxsight Inc (RXST) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Rxsight Inc (RXST) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
RxSight Stockholders Back Leadership at 2026 Annual Meeting - The Globe and Mail
Rxsight Inc (RXST) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Rxsight Inc (RXST) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Rxsight Inc (RXST) Institutional Confidence - TradingKey
Rxsight Inc (RXST) Valuation: PE, PB & Fair Value Analysis - TradingKey
Rxsight Inc (RXST) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
RxSight (RXST) investors re-elect board, approve pay and ratify Ernst & Young - Stock Titan
RxSight Inc Stock (US78419L1008): Valuation Focus After Strong Run In Eye Technology - AD HOC NEWS
RxSight, Inc. Hits 52-Week Low of $4.58 Amidst 92.2% Decline - MarketsMojo
RxSight, Inc. Stock Plummets to New 52-Week Low of $4.49 - MarketsMojo
RxSight, Inc. (RXST) Reports Q3 Loss, Tops Revenue Estimates - MSN
RxSight Inc. (RXST) Falters Near Support: Testing Key Levels After 1.96% DeclineDark Pool Sentiment - newsline.com
Understanding Momentum Shifts in (RXST) - Stock Traders Daily
RxSight, Inc. Hits 52-Week Low at $5.31 Amid Ongoing Struggles - MarketsMojo
RxSight, Inc. Hits 52-Week Low at USD 4.93 Amidst Ongoing Struggles - MarketsMojo
RxSight Inc. (RXST) Slides 3% as Stock Struggles Below Key Resistance at $5.03Put Wall - newsline.com
RxSight Inc. (RXST) Q1 2026 Earnings: EPS Miss Weighs on Shares Amid Operating ChallengesProfitability Analysis - newsline.com
RXST Technical Analysis & Stock Price Forecast - Intellectia AI
RxSight Inc stock (US78419L1008): Nasdaq-listed eye-care specialist in focus after recent price weak - AD HOC NEWS
RXST Q1 2026 Earnings: EPS Misses Estimates by a Wide Margin; Stock DeclinesEarnings Call Highlights - newsline.com
RxSight Inc. (RXST) Slips 4.65% as Stock Challenges $5.06 Support LevelTICK Divergence - The Legal Advocate
RxSight Securities Lawsuit Advances After Court Denies Dismissal Bid - TipRanks
RXST Q1 2026 Earnings: EPS Misses Estimates Amid Ongoing Ramp-UpEPS Growth Rate - The Legal Advocate
RXSTRxSight Inc Stock Price and Quote - Finviz
2.62%
2.25%
大文字化:
|
ボリューム (24 時間):